Vaxcyte, Inc.
PCVX- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
近 90 天，Vaxcyte, Inc. 內部人申報 0 筆公開市場買進、7 筆賣出；2026 年第 2 季末有 333 家機構在 13F 申報持有，市值合計 $97.1 億；大師中只有Maverick 資本持有。
SEC 申報
Vaxcyte, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F，最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀；8-K 的新聞稿等附件（例如 Item 2.02 的 EX-99.1）在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/4 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/11/4 | 8-K | 2.029.01 | 2026/11/4 | SEC | 目錄 |
| 2026/10/9 | 8-K | 1.012.038.019.01 | 2026/10/6 | SEC | 目錄 |
| 2026/10/5 | 8-K | 7.018.019.01 | 2026/10/5 | SEC | 目錄 |
| 2026/9/3 | 8-K | 5.027.019.01 | 2026/8/31 | SEC | 目錄 |
| 2026/8/5 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/5 | 8-K | 2.029.01 | 2026/8/5 | SEC | 目錄 |
| 2026/7/15 | 8-K | 5.02 | 2026/7/13 | SEC | 目錄 |
| 2026/6/23 | 8-K | 5.02 | 2026/6/17 | SEC | 目錄 |
| 2026/6/16 | 8-K | 5.07 | 2026/6/15 | SEC | 目錄 |
| 2026/5/6 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/6 | 8-K | 2.029.01 | 2026/5/6 | SEC | 目錄 |
| 2026/2/24 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/2/24 | 8-K | 2.029.01 | 2026/2/24 | SEC | 目錄 |
| 2026/2/24 | 8-K | 8.019.01 | 2026/2/24 | SEC | 目錄 |
| 2026/2/2 | 8-K | 8.019.01 | 2026/1/29 | SEC | 目錄 |
| 2025/12/19 | 8-K | 5.029.01 | 2025/12/18 | SEC | 目錄 |
| 2025/11/4 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/4 | 8-K | 2.029.01 | 2025/11/4 | SEC | 目錄 |
| 2025/9/30 | 8-K | 1.01 | 2025/9/24 | SEC | 目錄 |
| 2025/8/6 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/6 | 8-K | 2.029.01 | 2025/8/6 | SEC | 目錄 |
| 2025/6/17 | 8-K | 5.07 | 2025/6/12 | SEC | 目錄 |
| 2025/5/7 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/7 | 8-K | 2.029.01 | 2025/5/7 | SEC | 目錄 |
| 2025/5/1 | 8-K | 5.02 | 2025/5/1 | SEC | 目錄 |
| 2025/3/31 | 8-K | 7.018.019.01 | 2025/3/31 | SEC | 目錄 |
| 2025/2/25 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/2/25 | 8-K | 2.029.01 | 2025/2/25 | SEC | 目錄 |
| 2024/11/21 | 8-K | 1.018.01 | 2024/11/15 | SEC | 目錄 |
| 2024/11/5 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/5 | 8-K | 2.029.01 | 2024/11/5 | SEC | 目錄 |
| 2024/9/6 | 8-K | 8.019.01 | 2024/9/4 | SEC | 目錄 |
| 2024/9/3 | 8-K | 7.018.019.01 | 2024/9/3 | SEC | 目錄 |
| 2024/8/6 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/6 | 8-K | 2.029.01 | 2024/8/6 | SEC | 目錄 |
| 2024/7/2 | 8-K | 5.02 | 2024/6/27 | SEC | 目錄 |
| 2024/6/10 | 8-K | 5.07 | 2024/6/6 | SEC | 目錄 |
| 2024/5/8 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/8 | 8-K | 2.029.01 | 2024/5/8 | SEC | 目錄 |
| 2024/2/27 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/2/27 | 8-K | 2.029.01 | 2024/2/27 | SEC | 目錄 |
| 2024/1/31 | 8-K | 8.019.01 | 2024/1/30 | SEC | 目錄 |
| 2023/11/28 | 8-K | 5.02 | 2023/11/27 | SEC | 目錄 |
| 2023/11/27 | 8-K | 1.01 | 2023/11/21 | SEC | 目錄 |
| 2023/11/6 | 10-Q | – | 2023/9/30 | SEC | 目錄 |
| 2023/11/6 | 8-K | 2.029.01 | 2023/11/6 | SEC | 目錄 |
| 2023/10/16 | 8-K | 1.01 | 2023/10/13 | SEC | 目錄 |
| 2023/10/4 | 8-K | 1.01 | 2023/9/28 | SEC | 目錄 |
| 2023/9/7 | 8-K | 1.01 | 2023/9/1 | SEC | 目錄 |